Abiopharma

Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851

SL Green Realty Corp. Announces Annual Ordinary Dividend of $2.47 per Share

Mobileye Secures Major DMS Production Program with Leading U.S. Automaker

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results

ASP Isotopes Completes Well Drilling Required for Phase 1 of Renergen Helium Project Four Months Ahead of Schedule

Lufax Holding Ltd Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – LU

Ridgepost Capital Announces Retirement of Mark Hood as EVP and CAO

State Street Elects Susan Gordon to Its Board of Directors

Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services

Anavex Presents New AD-004 Phase IIb/III Data at AD/PD 2026 Showing Correlation Between Blarcamesine and Brain Volume in Alzheimer’s